Molecular Imaging Market

FMI opines the molecular imaging market is at a Theranostics Inflection Point, where the integration of diagnostic imaging with targeted radiopharmaceutical therapy is collapsing the boundary between diagnosis and treatment, creating a single-vendor revenue stream that spans from isotope production through imaging acquisition to therapeutic delivery.